Herpesvirus saimiri antagonizes nuclear domain 10-instituted intrinsic immunity via an ORF3-mediated selective degradation of cellular protein Sp100

Journal of Virology

Volumn 86, Issue 7, 2012, Pages 3541-3553

  Full, Florian ^a   Reuter, Nina ^a   Zielke, Katrin ^a   Stamminger, Thomas ^a   Ensser, Armin ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; DAXX PROTEIN; FORMYLGLYCINAMIDE RIBOTIDE AMIDOTRANSFERASE; NUCLEAR PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN ATRX; PROTEIN BNRF 1; PROTEIN ORF75C; PROTEIN SP100; TRANSFERASE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CELL NUCLEUS INCLUSION BODY; CELLULAR IMMUNITY; CONTROLLED STUDY; EPSTEIN BARR VIRUS; EVOLUTION; GAMMAHERPESVIRINAE; GAMMAHERPESVIRUS 68; GENE DELETION; HERPES VIRUS SAIMIRI; HUMAN; HUMAN CELL; NONHUMAN; NUCLEAR DOMAIN 10; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN TARGETING; SEQUENCE HOMOLOGY; VIRUS CELL INTERACTION; VIRUS INHIBITION; WILD TYPE;

ANTIGENS, NUCLEAR; AUTOANTIGENS; CELL LINE; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 2, SAIMIRIINE; HUMANS; IMMUNITY; NUCLEAR PROTEINS; OPEN READING FRAMES; PROTEIN BINDING; VIRAL PROTEINS;

HUMAN HERPESVIRUS 4; MURINAE; RHADINOVIRUS; SAIMIRIINE HERPESVIRUS 2;

EID: 84861303373     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06992-11     Document Type: Article

References (47)

1. Adler H, Messerle M, Koszinowski UH. 2003. Cloning of herpesviral genomes as bacterial artificial chromosomes. Rev. Med. Virol. 13:111- 121.
2. Adler M, Tavalai N, Muller R, Stamminger T. 2011. Human cytomegalovirus immediate-early gene expression is restricted by the nuclear domain 10 component Sp100. J. Gen. Virol. 92:1532-1538.
3. Bieniasz PD. 2004. Intrinsic immunity: a front-line defense against viral attack. Nat. Immunol. 5:1109 -1115.
4. Biesinger B, et al. 1992. Stable growth transformation of human T lymphocytes by herpesvirus saimiri. Proc. Natl. Acad. Sci. U. S. A. 89:3116- 3119.
5. Boutell C, et al. 2011. A viral ubiquitin ligase has substrate preferential SUMO targeted ubiquitin ligase activity that counteracts intrinsic antiviral defence. PLoS Pathog. 7:e1002245.
6. Chang PC, et al. 2010. Kaposi's sarcoma-associated herpesvirus (KSHV) encodes a SUMO E3 ligase that is SIM-dependent and SUMO-2/3-specific. J. Biol. Chem. 285:5266 -5273.
7. Chelbi-Alix MK, de The H. 1999. Herpes virus induced proteasomedependent degradation of the nuclear bodies-associated PML and Sp100 proteins. Oncogene 18:935-941.
8. Cuchet D, et al. 2011. PML isoforms I and II participate in PMLdependent restriction of HSV-1 replication. J. Cell Sci. 124:280 -291.
9. Ensser A, Pflanz R, Fleckenstein B. 1997. Primary structure of the alcelaphine herpesvirus 1 genome. J. Virol. 71:6517- 6525.
10. Ensser A, Thurau M, Wittmann S, Fickenscher H. 2003. The genome of herpesvirus saimiri C488 which is capable of transforming human T cells. Virology 314:471- 487.
11. Everett RD, Chelbi-Alix MK. 2007. PML and PML nuclear bodies: implications in antiviral defence. Biochimie 89:819-830.
12. Everett RD, et al. 2006. PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0. J. Virol. 80:7995- 8005.
13. Fleckenstein B, Desrosiers RC. 1982. Herpesvirus saimiri and herpesvirus ateles, p 253-332. In Roizman B (ed), The herpesviruses, vol 1. Plenum Press, New York, NY.
14. Gaspar M, Gill MB, Losing JB, May JS, Stevenson PG. 2008. Multiple functions for ORF75c in murid herpesvirus-4 infection. PLoS One 3:e2781.
15. Hensel GM, et al. 1996. Intracellular localization and expression of the human cytomegalovirus matrix phosphoprotein pp71 (ppUL82): evidence for its translocation into the nucleus. J. Gen. Virol. 77(Pt 12):3087- 3097.
16. Hofmann H, Sindre H, Stamminger T. 2002. Functional interaction between the pp71 protein of human cytomegalovirus and the PMLinteracting protein human Daxx. J. Virol. 76:5769 -5783.
17. Ishov AM, et al. 1999. PML is critical for ND10 formation and recruits the PML-interacting protein Daxx to this nuclear structure when modified by SUMO-1. J. Cell Biol. 147:221-234.
18. Jahn G, et al. 1984. Predominant immediate-early transcripts of human cytomegalovirus AD 169. J. Virol. 49:363-370.
19. Katano H, Ogawa-Goto K, Hasegawa H, Kurata T, Sata T. 2001. Human-herpesvirus-8-encoded K8 protein colocalizes with the promyelocytic leukemia protein (PML) bodies and recruits p53 to the PML bodies. Virology 286:446-455.
20. Kim YE, et al. 2011. Human cytomegalovirus infection causes degradation of Sp100 proteins that suppress viral gene expression. J. Virol. 85: 11928-11937.
21. Larkin MA, et al. 2007. Clustal W and Clustal X version 2.0. Bioinformatics 23:2947-2948.
22. Lee HR, et al. 2004. Ability of the human cytomegalovirus IE1 protein to modulate sumoylation of PML correlates with its functional activities in transcriptional regulation and infectivity in cultured fibroblast cells. J. Virol. 78:6527- 6542.
23. Ling PD, Tan J, Sewatanon J, Peng R. 2008. Murine gammaherpesvirus 68 open reading frame 75c tegument protein induces the degradation of PML and is essential for production of infectious virus. J. Virol. 82:8000-8012.
24. Marcos-Villar L, et al. 2009. Kaposi's sarcoma-associated herpesvirus protein LANA2 disrupts PML oncogenic domains and inhibits PMLmediated transcriptional repression of the survivin gene. J. Virol. 83: 8849-8858.
25. Medveczky P, Szomolanyi E, Desrosiers RC, Mulder C. 1984. Classification of herpesvirus saimiri into three groups based on extreme variation in a DNA region required for oncogenicity. J. Virol. 52:938 -944.
26. Melendez LV, Daniel MD, Hunt RD, Garcia FG. 1968. An apparently new herpesvirus from primary kidney cultures of the squirrel monkey (Saimiri sciureus). Lab. Anim. Care 18:374 -381.
27. Messerle M, Crnkovic I, Hammerschmidt W, Ziegler H, Koszinowski UH. 1997. Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome. Proc. Natl. Acad. Sci. U. S. A. 94: 14759-14763.
28. Muller S, Dejean A. 1999. Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins, correlating with nuclear body disruption. J. Virol. 73:5137-5143.
29. Nisole S, Stoye JP, Saib A. 2005. TRIM family proteins: retroviral restriction and antiviral defence. Nat. Rev. Microbiol. 3:799-808.
30. Parkinson J, Everett RD. 2000. Alphaherpesvirus proteins related to herpes simplex virus type 1 ICP0 affect cellular structures and proteins. J. Virol. 74:10006 -10017.
31. Rozen R, Sathish N, Li Y, Yuan Y. 2008. Virion-wide protein interactions of Kaposi's sarcoma-associated herpesvirus. J. Virol. 82:4742- 4750.
32. Saffert RT, Kalejta RF. 2006. Inactivating a cellular intrinsic immune defense mediated by Daxx is the mechanism through which the human cytomegalovirus pp71 protein stimulates viral immediate-early gene expression. J. Virol. 80:3863-3871.
33. Sawyer SL, Wu LI, Emerman M, Malik HS. 2005. Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain. Proc. Natl. Acad. Sci. U. S. A. 102:2832-2837.
34. Schäfer A, et al. 2003. The latency-associated nuclear antigen homolog of herpesvirus saimiri inhibits lytic virus replication. J. Virol. 77:5911-5925.
35. Sievers F, et al. 2011. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol. Syst. Biol. 7:539.
36. Tavalai N, Adler M, Scherer M, Riedl Y, Stamminger T. 2011. Evidence for a dual antiviral role of the major nuclear domain 10 component Sp100 during the immediate-early and late phases of the human cytomegalovirus replication cycle. J. Virol. 85:9447-9458.
37. Tavalai N, Papior P, Rechter S, Leis M, Stamminger T. 2006. Evidence for a role of the cellular ND10 protein PML in mediating intrinsic immunity against human cytomegalovirus infections. J. Virol. 80:8006-8018.
38. Tavalai N, Stamminger T. 2008. New insights into the role of the subnuclear structure ND10 for viral infection. Biochim. Biophys. Acta 1783: 2207-2221.
39. Tavalai N, Stamminger T. 2009. Interplay between herpesvirus infection and host defense by PML nuclear bodies. Viruses 1:1240 -1264.
40. Tischer BK, Smith GA, Osterrieder N. 2010. En passant mutagenesis: a two step markerless red recombination system. Methods Mol. Biol. 634:421-430.
41. Tischer BK, von Einem J, Kaufer B, Osterrieder N. 2006. Two-step red-mediated recombination for versatile high-efficiency markerlessDNA manipulation in Escherichia coli. Biotechniques 40:191-197.
42. Toptan T, Ensser A, Fickenscher H. 2010. Rhadinovirus vector-derived human telomerase reverse transcriptase expression in primary T cells. Gene Ther. 17:653- 661.
43. Tsai K, Thikmyanova N, Wojcechowskyj JA, Delecluse HJ, Lieberman PM. 2011. EBV tegument protein BNRF1 disrupts DAXX-ATRX to activate viral early gene transcription. PLoS Pathog. 7:e1002376.
44. Wu FY, et al. 2001. Origin-independent assembly of Kaposi's sarcomaassociated herpesvirus DNA replication compartments in transient cotransfection assays and association with the ORF-K8 protein and cellular PML. J. Virol. 75:1487-1506.
45. Yakushko Y, et al. 2011. Kaposi's sarcoma-associated herpesvirus bacterial artificial chromosome contains a duplication of a long unique-region fragment within the terminal repeat region. J. Virol. 85:4612- 4617.
46. Zhang Y, Buchholz F, Muyrers JP, Stewart AF. 1998. A new logic for DNA engineering using recombination in Escherichia coli. Nat. Genet. 20:123-128.
47. Zielke K, et al. 2012. The insulator protein CTCF binding sites in the orf73/LANA promoter region of herpesvirus saimiri (HVS) are involved in conferring episomal stability in latently infected human T-cells. J. Virol. 86:1862-1873.